Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

Lifestyle interventions that fully integrate the experiences of Black women into their treatment may produce better results.

Jim Gaffigan has revealed using a weight-loss drug gave him a "better life". The comedian wants to challenge the stigma ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

What price perfection? It's a question I ask every time I read another tragic story about a woman who's flown abroad for ...

Gaffigan slimmed down using Mounjaro, which is a brand name for tirzepatide, a prescription drug used to treat type 2 ...

Jim Gaffigan has a sleek new look to match his recent Hollywood renaissance, which includes his hilarious turn on SNL as vice ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...